The safety of immunizing with tetanus–diphtheria–acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak

This publication has 10 references indexed in Scilit:

• Ability of Healthcare Workers to Recall Previous Receipt of Tetanus-Containing Vaccination
  Infection Control & Hospital Epidemiology, 2010
• Risk of medically attended local reactions following diphtheria toxoid containing vaccines in adolescents and young adults: A Vaccine Safety Datalink study
  Vaccine, 2009
• An assessment of the safety of adolescent and adult tetanus–diphtheria–acellular pertussis (Tdap) vaccine, using active surveillance for adverse events in the Vaccine Safety Datalink
  Vaccine, 2009
• Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: A placebo-controlled trial
  Human Vaccines, 2009
• A “New Age” in Pertussis Prevention: New Opportunities Through Adult Vaccination
  American Journal of Preventive Medicine, 2007
• Reporting of Noninferiority and Equivalence Randomized Trials
  JAMA, 2006
• How Soon After a Prior Tetanus-Diphtheria Vaccination Can One Give Adult Formulation Tetanus-Diphtheria-Acellular Pertussis Vaccine?
  The Pediatric Infectious Disease Journal, 2006
• Efficacy of an Acellular Pertussis Vaccine among Adolescents and Adults
  New England Journal of Medicine, 2005
• Combined Tetanus, Diphtheria, and 5-Component Pertussis Vaccine for Use in Adolescents and Adults
  JAMA, 2005
• Adverse Events Associated With Childhood Vaccines Other Than Pertussis and Rubella
  Published by American Medical Association (AMA) ,1994